Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Long-Term Debt Repayments (2016 - 2019)

Altimmune (ALT) has disclosed Long-Term Debt Repayments for 6 consecutive years, with $105062.0 as the latest value for Q4 2019.

  • Quarterly Long-Term Debt Repayments changed N/A to $105062.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $135857.0 through Dec 2020, changed 0.0% year-over-year, with the annual reading at $632000.0 for FY2020, 116.44% up from the prior year.
  • Long-Term Debt Repayments for Q4 2019 was $105062.0 at Altimmune, up from $30795.0 in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $105062.0 in Q4 2019, with the low at -$250009.0 in Q3 2015.
  • Average Long-Term Debt Repayments over 4 years is -$64639.6, with a median of $8017.0 recorded in 2016.
  • The sharpest move saw Long-Term Debt Repayments dropped 0.0% in 2015, then surged 15995.96% in 2017.
  • Over 4 years, Long-Term Debt Repayments stood at -$250009.0 in 2015, then skyrocketed by 132.4% to $80999.0 in 2016, then tumbled by 80.33% to $15935.0 in 2017, then surged by 559.32% to $105062.0 in 2019.
  • According to Business Quant data, Long-Term Debt Repayments over the past three periods came in at $105062.0, $30795.0, and $15935.0 for Q4 2019, Q3 2019, and Q2 2017 respectively.